The association between nausea and vomiting of pregnancy and postpartum depression symptoms: a longitudinal study

Hongling Zhang1,2, Siyi San3, Xingjuan Ding4

  • 1School of Health and Nursing, Wuchang University of Technology, Wuhan, 430000, Hubei, China. zhl1965@whpu.edu.cn.

Scientific Reports
|February 3, 2026
PubMed

To investigate the incidence of nausea and vomiting of pregnancy (NVP) and postpartum depression symptoms (PPDS) in Wuhan, and to explore the relationship between different degrees of NVP and PPDS. 3061 pregnant women who underwent admission check-ups, delivery, and postpartum follow-up at the Women and Children's Hospital of Wuhan between October 2016 and October 2019 were selected for this study. NVP in the first trimester was assessed by a single question in the questionnaire. PPDS was assessed using the Edinburgh Postnatal Depression Scale (EPDS). Binary logistic regression models were used to estimate the risk of different degrees of NVP and PPDS. (1) The detection rate of NVP in early pregnancy and PPDS was 64.0% and 16.0%. (2) The detection rate of depressive symptoms at 1 and 6 months postpartum was 16.8% and 13.6%, respectively. (3) Binary logistic regression analysis revealed that severe NVP increased the risk of PPDS at 1 and 6 months postpartum. After adjusting for covariates, pregnant women with severe NVP had a 2.39-fold (95% CI 1.18-4.84) and 2.66-fold (95% CI 1.20-5.93) risk of developing PPDS 1 month and 6 months after delivery, respectively, compared with those without NVP. The incidence of NVP in the first trimester and PPDS in Wuhan is consistent with previous literature. Severe NVP in the first trimester is associated with an increased risk of depression at 1 and 6 months postpartum.

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
784
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
669
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
887
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
622
Longitudinal Studies01:26

Longitudinal Studies

Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
532
Longitudinal Research02:20

Longitudinal Research

Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
13.3K